Genzyme’s LEMTRADA™ Application for MS Accepted for Review by the FDA

News   Jan 29, 2013

 
Genzyme’s LEMTRADA™ Application for MS Accepted for Review by the FDA
 
 
 

RELATED ARTICLES

Computational Model Underlines Need for Personalised Approach to Sepsis

News

A computational model of the human immune system has enabled researchers to explore the challenges of tackling sepsis.

READ MORE

Allergies and Asthma Possibly Linked to Female Hormones

News

Fluctuations in female sex hormones could play a role in the development of allergies and asthma, a major review of evidence suggests. Analysis of studies involving more than 500,000 women highlights a link between asthma symptoms and key life changes such as puberty and menopause. Further investigation could help explain why asthma is more common in boys than girls in childhood, but more common in teenage girls and women following puberty.

READ MORE

Tiny Kidneys: Building Better Models to Test Drugs

News

A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE